Thomas Mark Cavell-Taylor
Directeur/Membre du Conseil chez CPI Innovation Services Ltd.
Profil
Thomas Mark Cavell-Taylor is currently a Director at CPI Innovation Services Ltd.
He was previously an Executive Director at Nuformix Technologies Ltd.
Postes actifs de Thomas Mark Cavell-Taylor
| Sociétés | Poste | Début |
|---|---|---|
CPI Innovation Services Ltd.
 CPI Innovation Services Ltd. Information Technology ServicesTechnology Services Founded in 2006, CPI Innovation Services Ltd. is a subsidiary of Centre for Process Innovation Ltd. The company is based in Redcar, UK. The British company provides technology services and conducts research and development in testing and pilot scale production facilities. | Directeur/Membre du Conseil | 14/04/2010 |
Anciens postes connus de Thomas Mark Cavell-Taylor
| Sociétés | Poste | Fin |
|---|---|---|
Nuformix Technologies Ltd.
 Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Nuformix Technologies Ltd.
Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
CPI Innovation Services Ltd.
CPI Innovation Services Ltd. Information Technology ServicesTechnology Services Founded in 2006, CPI Innovation Services Ltd. is a subsidiary of Centre for Process Innovation Ltd. The company is based in Redcar, UK. The British company provides technology services and conducts research and development in testing and pilot scale production facilities. | Technology Services |
